report-image

Global Peanut Allergy Treatment Market: - Market Size, Share, Competition, Industry Trends and Opportunity Analysis and Forecast to 2028

  • OI-236
  • |
  • Published date: May, 2021
  • |
  • Life Sciences & Healthcare
  • |
  • Pages

•Global Peanut Allergy Market is estimated at USD XXXX million in 2020. The market is projected to reach USD XXXX million by 2028, at a CAGR of XX% during the forecast period.

•Peanut allergy is the most common of childhood food allergies. Around 2.5% of children suffered from peanut allergy in the United States. Peanut allergy can cause several allergic reactions including anaphylaxis. There is no approved treatment available for the peanut allergy, only the experimental drugs are used for the peanut allergy treatment.

•FDA is expected to approve one or more than one peanut allergy immunotherapy products for peanut allergy treatment. Companies such as DBV Technologies, Aimmune Therapeutics(Nestlé S.A.), Prota Therapeutics Pty Ltd., Camallergy are conducting clinical trials for the development of peanut allergy treatment products.

•Peanut allergy treatment market expected to gain significant growth rate over the forecast period as increasing number of clinics visit for allergy treatment. Increasing number of research and development for the launch of immunotherapy products expected to boost up growth opportunity for peanut allergy treatment market.

•Peanut allergy treatment market will spur over the forecast period as increasing investments, scientific developments, and commercial activities.

•Global Peanut Allergy Market is estimated at USD XXXX million in 2020. The market is projected to reach USD XXXX million by 2028, at a CAGR of XX% during the forecast period.

•Peanut allergy is the most common of childhood food allergies. Around 2.5% of children suffered from peanut allergy in the United States. Peanut allergy can cause several allergic reactions including anaphylaxis. There is no approved treatment available for the peanut allergy, only the experimental drugs are used for the peanut allergy treatment.

•FDA is expected to approve one or more than one peanut allergy immunotherapy products for peanut allergy treatment. Companies such as DBV Technologies, Aimmune Therapeutics(Nestlé S.A.), Prota Therapeutics Pty Ltd., Camallergy are conducting clinical trials for the development of peanut allergy treatment products.

•Peanut allergy treatment market expected to gain significant growth rate over the forecast period as increasing number of clinics visit for allergy treatment. Increasing number of research and development for the launch of immunotherapy products expected to boost up growth opportunity for peanut allergy treatment market.

•Peanut allergy treatment market will spur over the forecast period as increasing investments, scientific developments, and commercial activities.


REPORT YOU MIGHT BE INTERESTED

Choose Licence Type

$4,250.00
$5,450.00
Credit card Logo
Inquiry Before Buying

Related Reports


Contact Us

Email Us at: sales@optimainsights.org | Reach Us at: +91 966 6620 365 | +1 857 444 9369 (US)  tick-under  tick-under